Format

Send to

Choose Destination
J Postgrad Med. 2018 Oct-Dec;64(4):195-199. doi: 10.4103/jpgm.JPGM_41_18.

Enzyme replacement therapy in India: Lessons and insights.

Author information

1
Department of Pediatrics, Seth GS Medical College and KEM Hospital, Parel, Mumbai, Maharashtra, India.

Conflict of interest statement

Dr. Mamta Muranjan was Principal Investigator for study entitled "A Phase 3, randomized, multi-center, multi-national, double-blind study to evaluate the efficacy, safety, and pharmacokinetics of once daily versus twice daily dosing of Genz-112638 in patients with Gaucher disease type 1 who have demonstrated clinical stability on a twice daily dose of Genz-112638" which was funded by Sanofi-Genzyme. The grant was deposited with the Diamond Jubilee Society Trust of Seth G.S. Medical College and K.E.M. Hospital. She also serves as a Member of Sanofi-Genzyme's Indian Medical Advisory Board, a post that does not involve any remuneration.

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center